" (Karem et al., 1073)
With an increased focus today on the genetic implications of the condition, enhanced abilities to understand the behaviors of human DNA are opening the door to a more perceptive response to the condition in question. As the text by Davis (1993) indicates, "as mutational analysis and patient data continue to be compiled, patient genotyping should prove useful in both prognosticating and providing a framework for evaluating treatments. Furthermore, whether the heterozygous state of CF mutations predisposes to abnormalities such as chronic bronchial hypersecretion, airway hyperreactivity or infertility can now be more thoroughly addressed." (Davis, 17)
These factors are not just improving our understanding of what may cause cystic fibrosis, but it has also allowed us to pinpoint some strategies for controlling a condition that only 25 years ago, was seen as a pre-adulthood death sentence. As the table included in Appendix A demonstrates, the average...
[ View Full Essay]